Bioavailability Study of 6 Mercaptopurine in Crohns Disease Patients
Study Title
- Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients
Teva Identifier
- C1/13/6MP-02
ClinicalTrials.gov Identifier
- NCT00774982
Study Status
- Completed
Trial Condition(s)
- Crohns Disease
Interventions
- Drug: Delayed Release 6 mercaptopurine | Drug: 6 Mercaptopurine
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 50 Years
Trial Duration
- 12/01/2008 - 02/01/2009
Phase
- Phase 1
Study Type
Interventional
